UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
Phase 4
Withdrawn
- Conditions
- Type 1 Diabetes
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT00505882
- Locations
- ๐บ๐ธ
UT Southwestern at Dallas, Dallas, Texas, United States
Non-Interventional F-Two Isoprostane Trial (NIFTI)
Completed
- Conditions
- Traumatic Brain Injury
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2020-03-16
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00505908
- Locations
- ๐บ๐ธ
Parkland Memorial Hospital, Dallas, Texas, United States
Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2007-05-28
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT00479791
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
Pharmacokinetic Response to BPI in Burns
Phase 2
Terminated
- Conditions
- Burns
- Interventions
- Drug: BPI
- First Posted Date
- 2007-04-19
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT00462904
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both
Not Applicable
Completed
- Conditions
- Cholesterol, LDL
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2007-04-18
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 240
- Registration Number
- NCT00461968
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
Therapeutic Approaches to HAART-Induced Lipodystrophy
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2019-05-09
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 23
- Registration Number
- NCT00461552
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
Novel Therapies for Metabolic Complications of Lipodystrophies
Not Applicable
Completed
- Conditions
- Insulin ResistanceDiabetesHepatic SteatosisHypertriglyceridemia
- Interventions
- Other: low-fat diet ( Still recruiting )Other: Diet
- First Posted Date
- 2007-04-09
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT00457938
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
Cholic Acid for Hepatic Steatosis in Lipodystrophy
- First Posted Date
- 2007-04-06
- Last Posted Date
- 2019-01-17
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT00457639
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Mechanisms of Lipodystrophy in HIV-Infected Pateints
- First Posted Date
- 2007-04-06
- Last Posted Date
- 2019-07-18
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 56
- Registration Number
- NCT00457665
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Quetiapine for Bipolar Disorder and Alcohol Dependence
Phase 4
Completed
- Conditions
- Bipolar DisorderAlcohol Dependence
- Interventions
- Drug: PlaceboDrug: Quetiapine
- First Posted Date
- 2007-04-06
- Last Posted Date
- 2016-04-05
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT00457197
- Locations
- ๐บ๐ธ
Psychoneuroendocrine Research Program, Dallas, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath